Please assess the completion status of the following clinical trial:

Trial Title: Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with sever chronic intestinal disease requiring long term parenteral nutrition~* Receiving home lipid containing parenteral nutrition (LCPN), regardless of currently infused intravenous fat emulsion~* With a stable dose of LCPN for at least 1 month at recruitment time~* Administered at least 4 days a week through central venous access, with at least 150 mL of lipid per parenteral nutrition bag with lipid.~* Age \>18~* Being available for 2 medical consultations in a 6 month period~* Who gave its written informed consent to participate to the study and without legal protection~* Social security coverage~Exclusion Criteria:~* Lesser expected parenteral nutrition length than duration for the entire trial~* Dermatological criteria : History of skin disease (atopic dermatitis, psoriasis) or evolving skin disease, broken or inflamed skin on the TEWL measurement site, Use of topical creams on the TEWL measurement site, Skin or systemic allergy (asthma)~* Contraindication to one of the selected intravenous fat emulsion: Severe dyslipidemia; Uncontrolled diabetes; Sepsis; Severe hepatic impairment; Major blood clotting disorders; Egg protein, soybean, peanut or fish hyper sensibility; Serum creatinine clearance \< 30 ml/min

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- soybean oil (SO)-based IVFE (Medialipide) (Type: ACTIVE_COMPARATOR): None
- fish oil (FO)-containing IVFE (Lipidem) (Type: ACTIVE_COMPARATOR): fish oil (FO)-containing IVFE (Lipidem)

Based on this trial design, predict the completion outcome and termination type (if applicable).